Biogen (BIIB) Stock Surges On Earnings Release
Biogen Idec (NASDAQ:
BIIB -
News) shares gained 8.4% after the company reported substantially higher third-quarter earnings, due to increased drug sales and hefty accounting charges taken during the 2005 quarter.
This site is not affiliated with Mr. James Cramer, and is not associated with any television networks or broadcasts. Data presented on this site should not be used to make investment decisions and accuracy cannot be guaranteed
GRB Holding Co., LLC
0 Comments:
Post a Comment
<< Home